474 related articles for article (PubMed ID: 8057421)
1. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
[TBL] [Abstract][Full Text] [Related]
2. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
Ling PD; Rawlins DR; Hayward SD
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9237-41. PubMed ID: 8415684
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.
Fuentes-Pananá EM; Ling PD
J Virol; 1998 Jan; 72(1):693-700. PubMed ID: 9420275
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21.
Radkov SA; Bain M; Farrell PJ; West M; Rowe M; Allday MJ
J Virol; 1997 Nov; 71(11):8552-62. PubMed ID: 9343213
[TBL] [Abstract][Full Text] [Related]
5. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
Johannsen E; Koh E; Mosialos G; Tong X; Kieff E; Grossman SR
J Virol; 1995 Jan; 69(1):253-62. PubMed ID: 7983717
[TBL] [Abstract][Full Text] [Related]
7. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
Sjöblom A; Nerstedt A; Jansson A; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.
Wang F; Kikutani H; Tsang SF; Kishimoto T; Kieff E
J Virol; 1991 Aug; 65(8):4101-6. PubMed ID: 1649318
[TBL] [Abstract][Full Text] [Related]
9. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
Zhao B; Sample CE
J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).
Fuentes-Pananá EM; Swaminathan S; Ling PD
J Virol; 1999 Jan; 73(1):826-33. PubMed ID: 9847397
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
Laux G; Dugrillon F; Eckert C; Adam B; Zimber-Strobl U; Bornkamm GW
J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
[TBL] [Abstract][Full Text] [Related]
12. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
Ling PD; Ryon JJ; Hayward SD
J Virol; 1993 Jun; 67(6):2990-3003. PubMed ID: 8388484
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
Cohen JI; Wang F; Kieff E
J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028
[TBL] [Abstract][Full Text] [Related]
15. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
Henkel T; Ling PD; Hayward SD; Peterson MG
Science; 1994 Jul; 265(5168):92-5. PubMed ID: 8016657
[TBL] [Abstract][Full Text] [Related]
16. The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulation.
Szenthe K; Koroknai A; Banati F; Bathori Z; Niller HH; Wolf H; Nagy N; Klein E; Minarovits J; Salamon D
Biochem Biophys Res Commun; 2013 May; 435(1):8-15. PubMed ID: 23583387
[TBL] [Abstract][Full Text] [Related]
17. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
Peng R; Moses SC; Tan J; Kremmer E; Ling PD
J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
19. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
20. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1.
Ambinder RF; Mullen MA; Chang YN; Hayward GS; Hayward SD
J Virol; 1991 Mar; 65(3):1466-78. PubMed ID: 1847464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
